Performance Study of a Non-invasive Glucose Monitoring Device Prototype

R

RSP Systems

Status

Completed

Conditions

Diabetes Mellitus

Treatments

Device: P0.1

Study type

Interventional

Funder types

Industry

Identifiers

NCT03519841
RSP-13

Details and patient eligibility

About

This clinical study has been launched to collect spectral Raman data paired with validated glucose reference values in private homes of subjects.

Full description

Protocol consists of two parts: Part A) Subjects will collect spectral Raman data on device every 15 minutes for 10 hours a day for five days. The five days will be distributed within a timeframe of ten days. A Flash Glucose Monitor will be used as a comparator. In addition to this, four daily capillary Blood Glucose readings will be collected. Part B) Subjects will perform four daily measuring sessions in which optical Raman readings are paired with capillary Blood Glucose comparator. Measuring sessions are performed in subjects' own home while maintaining usual diabetes management routines. Subjects will collect data for 30 days during a 60 days' period.

Enrollment

6 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male and female subjects 18 years of age or older
  • Diabetic patients (all types), insulin requiring
  • Skin phototype 1-4

Exclusion criteria

  • For female participants: Pregnancy or subject is attempting to conceive or not willing and able to practice birth control during the study duration
  • For female participants: Breastfeeding
  • Subjects not able to understand and read Danish
  • In Investigator's opinion, subject is not able to follow instructions as specified in the protocol
  • Rejection by optical screenings
  • Participants not able to hold hand/arm steadily (including tremors and Parkinson's Disease)
  • Diagnosed with reduced circulation
  • Extensive skin changes, tattoos or diseases on probe application site
  • Known allergy to medical grade alcohol
  • Known allergy to adhesives, applicable to subjects in RSP-13-01
  • Systemic or topical administration of glucocorticoids for the past 7 days
  • Subjects undergoing dialysis treatment
  • Medical history or any condition that may, in the opinion of the Investigator, compromise the subject's ability to participate
  • Concomitant medical condition which could present a risk to the safety or welfare of the subject or study staff.
  • Participants currently enrolled in another study

Trial design

Primary purpose

Device Feasibility

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

6 participants in 2 patient groups

RSP-13-01
Experimental group
Description:
Experimental: IMD data collection Subjects will intensively collect spectral Raman data on P0.1 in a home-based setting for 5 days. Data will be paired with reference measurements.
Treatment:
Device: P0.1
RSP-13-02
Experimental group
Description:
Experimental: IMD data collection Subjects will collect spectral Raman data on P0.1 during four measuring sessions a day for 30 days distributed over a time period of 60 days. Each timepoint is conducted in duplicate. Spectral data will be compared to standard BG measurements.
Treatment:
Device: P0.1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems